Soleus PE GP III, LLC insider trades: Parabilis Medicines (PBLS) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Soleus PE GP III, LLC reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | PBLS | ↑ Buy | 500,000 | $20.00 | $10.0M | Indirect | Jun 29, 2026 (18d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PBLS insiders
Open-market trades in the last 12 months
About Soleus PE GP III, LLC's insider trades
Soleus PE GP III, LLC is a 10% owner of Parabilis Medicines (PBLS). Since Jun 11, 2026, it has reported 1 open-market purchase worth $10.0M and no sales on SEC Form 4. In the last 12 months: 1 buy ($10.0M).
Its filings also include conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.